Dudediligence.

Hemab Therapeutics Holdings, Inc

COAGNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Sep 248-KOfficer or director change5.02
  2. Aug 1413GPassive stake of 5% or more (13G), filed by Novo Holdings A/S
  3. Aug 1413GPassive stake of 5% or more (13G), filed by Avoro Capital Advisors
  4. Aug 1213GPassive stake of 5% or more (13G), filed by Capital International Investors
  5. Aug 1110-QQuarterly report
  6. Aug 118-KResults of operations2.029.01
  7. Aug 713GPassive stake of 5% or more (13G), filed by Invus Global Management
  8. Aug 613GPassive stake of 5% or more (13G), filed by Fmr
  9. Aug 513GPassive stake of 5% or more (13G), filed by Sofinnova Crossover II S.L.P.
  10. May 2110-QQuarterly report
  11. May 218-KResults of operations2.029.01
  12. May 118-KOfficer or director change5.02
  13. May 48-KBylaws or fiscal year changed and other events5.038.019.01
  14. May 1424B4Prospectus for an offering
  15. Apr 10S-1Registration of new shares